| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 10, 2025 | Dec 12, 2025 | Avalo Therapeutics, Inc. | CFO | Sell | 37.5 | -155 | -0.89% | ✗ | $635.5 |
| Mar 28, 2025 | Apr 1, 2025 | Avalo Therapeutics, Inc. | CFO | Sell | 22.5 | -7,285 | -30.10% | ✗ | $61.6K |
| Jun 9, 2023 | Jun 13, 2023 | Avalo Therapeutics, Inc. | CFO | Buy | 90.0 | +511 | 68.04% | ✗ | $1.7K |
| Dec 10, 2021 | Dec 14, 2021 | Avalo Therapeutics, Inc. | Chief Accounting Officer | Buy | 90.0 | +955 | 11.86% | ✗ | $1.5K |
| Dec 10, 2020 | Dec 14, 2020 | Avalo Therapeutics, Inc. | CFO | Buy | 91.3 | +5,095 | 172.48% | ✗ | $11.6K |
| Jun 10, 2020 | Jun 11, 2020 | Avalo Therapeutics, Inc. | CFO | Buy | 90.0 | +2,954 | 100.00% | ✗ | $6.7K |